HCM
BEAT

HMS Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

HMS Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,100
Closed -$69K – 285
2019
Q1 		$69K Hold
1,100
– – 0.03% 162
2018
Q4 		$66K Hold
1,100
– – 0.03% 171
2018
Q3 		$71K Buy
+1,100
New +$61.4K 0.04% 186

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

HMS Capital Management's BEAT Position: Q3 2019 in Review

HMS Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 8,205 shares — an estimated $395K sold.

HMS Capital Management first reported a position in BEAT in Q2 2018 and held it in 5 quarters. The position peaked at $629K in Q3 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • HMS Capital Management reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
  • HMS Capital Management sold 8,205 BioTelemetry, Inc. shares in Q3 2019, an estimated $395K.
  • HMS Capital Management first reported a position in BioTelemetry, Inc. in Q2 2018 and held it in 5 quarters.
  • HMS Capital Management's BioTelemetry, Inc. position peaked at $629K in Q3 2018.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on HMS Capital Management's 13F filing for Q3 2019, filed 15 Oct 2019.